Pharmax initiates operations at new Dubai facility

UAE-based Pharmax Pharmaceuticals has begun production out of its new $34 million facility located in Dubai Science Park. According to the company, the custom-built factory is the first advanced manufacturing facility to be opened in Dubai Science Park and is equipped with the latest European technology, meeting stringent global regulatory standards.

The factory has a current annual capacity of over 200 million tablet and capsule dosage forms, which is intended to increase in the next three to five years to over 800 million.

The company plans to produce medications targeting chronic conditions common in the Middle East and other developed markets, including cardiovascular diseases, psychiatric and neurological disorders, gastroenterological diseases, metabolic disorders such as hyperlipidemia and diabetes, central nervous system diseases, bacterial and viral infectious diseases, respiratory illnesses, asthma and allergies, bone and joint inflammation disorders and urological diseases.